Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

NIH 48 INDUSTRY 30 OTHER 20 NETWORK 4 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

Cisplatin 48 Capecitabine 41 Gemcitabine 33 apatinib 32 Oxaliplatin 32 Cyclophosphamide 31 Radiotherapy 29 Paclitaxel 29 Carboplatin 29 tislelizumab 27 Irinotecan 27 Drug Therapy 27 Fluorouracil 26 Docetaxel 26 Bevacizumab 23 fludarabine 18 Nivolumab 17 pembrolizumab 16 Surgical Procedures, Operative 16 Exercise 16 Metformin 15 S 1 (combination) 14 camrelizumab 13 Radiation 13 Pemetrexed 13 Control Groups 12 anlotinib 11 Leucovorin 11 Vinorelbine 10 Standard of Care 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Interventional × cediranib × Clear all

NCT00532194 2015-09-23

ICON6

Medical Research Council

Phase 3 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡